NCT03131778

Brief Summary

Patients with resectable liver metastases of colorectal origin will be assigned to laparoscopic liver resection or conventional open liver surgery. Blood samples will be drawn preoperatively and 24 hours after resection. Determination of Interleukin-6 (IL-6) and IL-8 will be done to assess the stress response between open and laparoscopic liver resection (Elisa test). The Messenger Ribonucleic Acid (mRNA) of inflammation related factors (cyclooxygenase-2 (COX-2) and Matrix metalloproteinase (MMP-9)), angiogenesis related factor (vascular endothelial growth factor (VEGF) and hypoxia induced factor-1 (HIF-1)) in tumor tissue and normal liver parenchyma will be detected by real-time real time-Polymerase Chain Reaction (RT-PCR).

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2010

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2010

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2011

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2011

Completed
5.8 years until next milestone

First Submitted

Initial submission to the registry

April 20, 2017

Completed
7 days until next milestone

First Posted

Study publicly available on registry

April 27, 2017

Completed
Last Updated

May 1, 2017

Status Verified

April 1, 2017

Enrollment Period

1.2 years

First QC Date

April 20, 2017

Last Update Submit

April 27, 2017

Conditions

Outcome Measures

Primary Outcomes (1)

  • Differences in inflammatory response

    Differences in POD 1 levels of IL6 and IL8

    Preoperative and postoperative day 1

Secondary Outcomes (3)

  • Differences in tumor stimulating factors

    One week after surgery

  • Overall Survival

    1-3-5 years

  • Recurrence free survival

    1-3-5 years

Study Arms (2)

Open Liver Resection

ACTIVE COMPARATOR

Conventional open liver resection trough subcostal incision

Procedure: Liver resection

Laparoscopic Liver Resection

EXPERIMENTAL

Pure laparoscopic liver resection without hand assistance

Procedure: Liver resection

Interventions

liver resections for colorectal liver metastases

Laparoscopic Liver ResectionOpen Liver Resection

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years old
  • Patients with colorectal liver metastases
  • Colorectal liver metastases ≤10 cm in size -

You may not qualify if:

  • Patients not fit for laparoscopic surgery due to comorbidities
  • Patients with tumors close or infiltrating the major vessels -

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (3)

  • Fretland AA, Sokolov A, Postriganova N, Kazaryan AM, Pischke SE, Nilsson PH, Rognes IN, Bjornbeth BA, Fagerland MW, Mollnes TE, Edwin B. Inflammatory Response After Laparoscopic Versus Open Resection of Colorectal Liver Metastases: Data From the Oslo-CoMet Trial. Medicine (Baltimore). 2015 Oct;94(42):e1786. doi: 10.1097/MD.0000000000001786.

    PMID: 26496309BACKGROUND
  • Ueda K, Turner P, Gagner M. Stress response to laparoscopic liver resection. HPB (Oxford). 2004;6(4):247-52. doi: 10.1080/13651820410023987.

    PMID: 18333082BACKGROUND
  • Buunen M, Gholghesaei M, Veldkamp R, Meijer DW, Bonjer HJ, Bouvy ND. Stress response to laparoscopic surgery: a review. Surg Endosc. 2004 Jul;18(7):1022-8. doi: 10.1007/s00464-003-9169-7. Epub 2004 May 12.

    PMID: 15136930BACKGROUND

MeSH Terms

Conditions

Liver NeoplasmsColorectal NeoplasmsNeoplasm Metastasis

Interventions

Hepatectomy

Condition Hierarchy (Ancestors)

Digestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesLiver DiseasesIntestinal NeoplasmsGastrointestinal NeoplasmsGastrointestinal DiseasesColonic DiseasesIntestinal DiseasesRectal DiseasesNeoplastic ProcessesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Digestive System Surgical ProceduresSurgical Procedures, Operative

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 20, 2017

First Posted

April 27, 2017

Study Start

April 1, 2010

Primary Completion

June 30, 2011

Study Completion

June 30, 2011

Last Updated

May 1, 2017

Record last verified: 2017-04

Data Sharing

IPD Sharing
Will not share